Jiao et al. (2023) reported that targeted removal of ANGPTL8 in vascular smooth muscle cells (VSMCs) mitigated AngII-induced hypertension and hypertensive cardiovascular remodelling. Here, ANGPTL8 is linked to hypertensive disorder.